Comparison of structured versus abstracted comorbidities using oncology EHR data from cancer patients in the Flatiron Health network Published May 2018 Citation Parrinello, CM, et al. . ISPOR Annual Meeting. . https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-com-pdf/ISPOR-Poster-Structured-vs-Unstructured-Comorbidities_Vertical_Final_MM.pdf Authors: Sources:ISPOR Annual Meeting Share Posted inPublicationsMethodology More publicationsISPORApril 2025Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLCLi X, Jarrett B, Kerr B, et al. Real-world evidencePublication summaryPublicationsMethodologyNon-small cell lung cancerESMO Real-World Data and Digital OncologyFebruary 2025Characterisation of oncology EHR-derived real-world data in the UK, Germany, and JapanAdamson B, Horne E, Xu C, et al.Real-world evidencePublication summaryPublicationsData scienceMethodologyHTA and market accessFrontiers in Drug Safety and RegulationAugust 2024Measurement error and bias in real-world oncology endpoints when constructing external control armsAckerman B, Gan R, Meyer C, et al. Publication summaryPublicationsMethodologyMultiple myeloma